KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Intuitive Surgical (ISRG) Research & Development (2016 - 2025)

Intuitive Surgical (ISRG) has 17 years of Research & Development data on record, last reported at $352.9 million in Q4 2025.

  • For Q4 2025, Research & Development rose 19.75% year-over-year to $352.9 million; the TTM value through Dec 2025 reached $1.3 billion, up 14.54%, while the annual FY2025 figure was $1.3 billion, 14.54% up from the prior year.
  • Research & Development reached $352.9 million in Q4 2025 per ISRG's latest filing, up from $329.4 million in the prior quarter.
  • Across five years, Research & Development topped out at $352.9 million in Q4 2025 and bottomed at $159.8 million in Q1 2021.
  • Average Research & Development over 5 years is $250.3 million, with a median of $247.2 million recorded in 2023.
  • Peak YoY movement for Research & Development: skyrocketed 33.1% in 2022, then rose 6.55% in 2023.
  • A 5-year view of Research & Development shows it stood at $183.4 million in 2021, then surged by 33.1% to $244.1 million in 2022, then grew by 6.55% to $260.1 million in 2023, then increased by 13.3% to $294.7 million in 2024, then increased by 19.75% to $352.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $352.9 million in Q4 2025, $329.4 million in Q3 2025, and $313.3 million in Q2 2025.